[{"id":"ced3ddfc-aecc-483f-b6ba-df1ba61c1bcc","acronym":"","url":"https://clinicaltrials.gov/study/NCT01999738","created_at":"2021-01-18T09:07:36.380Z","updated_at":"2024-07-02T16:37:03.004Z","phase":"Phase 1","brief_title":"Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT01999738","lead_sponsor":"Endocyte","biomarkers":" EGFR • PD-L1 • ALK • BRCA1 • BRCA2 • ROS1 • BRCA","pipe":" | ","alterations":" BRCA mutation","tags":["EGFR • PD-L1 • ALK • BRCA1 • BRCA2 • ROS1 • BRCA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e folate-tubulysin (EC1456)"],"overall_status":"Completed","enrollment":" Enrollment 93","initiation":"Initiation: 10/01/2013","start_date":" 10/01/2013","primary_txt":" Primary completion: 12/31/2017","primary_completion_date":" 12/31/2017","study_txt":" Completion: 04/26/2018","study_completion_date":" 04/26/2018","last_update_posted":"2019-02-07"}]